| Antibody responses after vaccination against equine influenza in Korea in 2016-2018 |
|
Min-Su Cho1, Ju-Yeon Lee1, Sang Kyu Lee2, Jae Young Song1, Jienny Lee1, Bang-Hun Hyun1, Soo-Dong Cho1, In-Ohk Ouh1 |
1Animal and Plant Quarantine Agency
2Korea Racing Authority |
| 2016년에서 2018년에 국내 말 인플루엔자 백신 접종 후 항체 양성률 |
|
조민수1, 이주연1, 이상규2, 송재영1, 이지현1, 현방훈1, 조수동1, 우인옥1 |
1농림축산검역본부
2한국마사회 |
Correspondence:
In-Ohk Ouh, Tel: 82-54-912-0802, Fax: 82-54-912-0812,
Email: dvmoio@korea.kr
|
|
|
| Abstract |
|
Equine influenza (EI) is the main cause of respiratory illness in equines across the globe and is caused by equine influenza A virus (EIV-A), which has impacted the equine industry internationally because of the marginal mortality and high morbidity. In the present study, the immune responses after equine influenza vaccination were evaluated in 4,144 horses in Korea using the hemagglutination inhibition (HI) assay. The equine influenza virus (EIV), A/equine/South Africa/4/03 (H3N8), was used as the antigen in the HI assay. The mean seropositive rates were 89.2% (97.4% in 2016, 77.6% in 2017, and 92.4% in 2018). This paper highlights the advances in understanding the effects of vaccines and control strategies for mitigating the emerging menace by EIV. |
| Key Words:
horse, equine influenza virus (EIV), hemagglutination inhibition (HI), antibody |
|
PDF Links
Full text via DOI
Download Citation
